Elizabeth E. Reed, SVP, GC & CORPORATE SECRETARY at Travere Therapeutics, Inc. (TVTX), sold 2,062 shares at $8.96 ($18K) on 2024-01-23, disclosed to the SEC on 2024-01-25.
Scheduled sale ($18k) by SVP, GC & CORPORATE SECRETARY under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-15 | $2.1M | — | Filing → |
| TVTX | SELL | 2026-04-02 | $300K | — | Filing → |
| TVTX | SELL | 2026-03-18 | $562K | — | Filing → |